Amgen Raises NC Investment to $1.5B with Plans for Second Plant
Amgen said today it will raise its biomanufacturing investment in Holly Springs, NC, to $1.5 billion, by establishing a second drug substance manufacturing plant there—thanks in part to nearly $5 million in economic subsidies from North Carolina. The …